Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
2,322,425
-
Shares change
-
+2,309,821
-
Total reported value, excl. options
-
$136,167,310
-
Value change
-
+$135,429,458
-
Number of buys
-
48
-
Number of sells
-
-1
-
Price
-
$58.62
Significant Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q2 2016
53 filings reported holding PPH - VANECK ETF TRUST - PHARMACEUTCL ETF as of Q2 2016.
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,322,425 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (1,514,862 shares), MORGAN STANLEY (182,246 shares), RAYMOND JAMES & ASSOCIATES (88,503 shares), Lumina Fund Management LLC (64,400 shares), Clal Insurance Enterprises Holdings Ltd (55,600 shares), CREDIT SUISSE AG/ (51,722 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (42,019 shares), Raymond James Financial Services Advisors, Inc. (35,335 shares), BANK OF AMERICA CORP /DE/ (31,815 shares), and STUYVESANT CAPITAL MANAGEMENT (27,360 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.